In the article, the author discusses the latest developments in systems biology (SB) industry as of January 2011. He cites the moves by SB firms GNS Healthcare and Selventa to change their names to reposition and improve their operations. The opinion of GNS Healthcare co-founder and chief executive officer (CEO) Colin Hill on the SB industry is also cited.